| |
 Technical Papers |
Product |
 |
Controlled Clinical Comparison of VersaTREK and BacT/ALERT Blood Culture Systems. Stanley Mirrett1, Kimberly E. Hanson1,2,3
and L. Barth Reller1,2,3.
Clinical Microbiology Laboratory, Duke Medical Center1, and Departments of Pathology2 and Medicine3, Duke University School of Medicine.
View Paper
Journal of Clinical Microbiology, February 2007, p. 299-302.
www.journals.asm.org |
VersaTREK® |
|
Intra- and Interlaboratory Study of a Method for Testing the Antifungal Susceptibilities of Dermatophytes. M.A. Ghannoum, V. Chaturvedi, A. Espinel-Ingroff, M.A. Pfaller, M.G. Rinaldi, W. Lee-Yang, and D.W. Warnock.
Journal of Clinical Microbiology, July 2004, p. 2977-2979.
www.journals.asm.org |
Sensititre® |
|
Quality Control Guidelines for BAL9141 (Ro 63-9141), an Investigational Cephalosporin, when Reference MIC and Standardized Disk Diffusion Susceptibility Test Methods are Used. T.R. Anderegg, R.N. Jones, H.S. Sader.
Journal of Clinical Microbiology, July 2004, p. 3356-3358.
www.journals.asm.org |
Sensititre® |
|
"Comparison of the ESP and BACTEC Systems for Testing Susceptibilities
of Mycobacterium tuberculosis Complex Isolates to Pyrazinamide."
Dr. Vincent J. LaBombardi
Department of Laboratories, St. Vincent's Hospital Manhattan, New York, and Department of Pathology,
New York Medical College, Valhalla, New York
Journal of Clinical Microbiology, June 2002, page
2238 – 2239
www.journals.asm.org |
ESP® |
| |
|
|
*For a complete list of technical papers in support of TREK products, please contact your local Area Account Manager.
|
|
